ANNA DECLERCQ: Open Payments
NPI 1467165266 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| PFIZER INC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, JARDIANCE, ZORYVE, UZEDY, AREXVY, Auvelity, ELIQUIS.
Industry payments across OH — which companies pay providers there.
